<p>Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus</p>-Reference-Cited by-同舟云学术

Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus

Published:2020-05 Issue: Volume:Volume 13 Page:1855-1861
ISSN:1178-7007
Container-title:Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
language:en
Short-container-title:DMSO

Author:

Tafere Gebrehiwot Gebremedhin^ORCID,Wondafrash Dawit Zewdu^ORCID,Zewdie Kaleab Alemayehu^ORCID,Assefa Brhane Teklebrhan^ORCID,Ayza Muluken Altaye^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology,Internal Medicine

Reference43 articles.

1. WHO. Classification of Diabetes Mellitus. World Health Organization; 2019:1–40. Licence: CC BY-NC-SA 3.0 IGO 2019.

Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications

3. Glycaemic Control for People with Type 2 Diabetes Mellitus in Bangladesh - An urgent need for optimization of management plan

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipose tissue–derived adipsin marks human aging in non-type 2 diabetes population;BMJ Open Diabetes Research & Care;2024-08

2. Comparative effects of 8-week combined resistance exercise training and alternate-day calorie restriction on soluble epidermal growth factor receptor (sEGFR) and adipsin in obese men;Growth Factors;2024-07-15

3. TM4SF19-mediated control of lysosomal activity in macrophages contributes to obesity-induced inflammation and metabolic dysfunction;Nature Communications;2024-03-30

4. Adipsin in the pathogenesis of cardiovascular diseases;Vascular Pharmacology;2024-03

5. Adipokines and their role in acute pancreatitis;Journal of Medical Biochemistry;2024